Outcome | Metformin | Placebo | p value |
---|---|---|---|
Open label antiglycemic agenta | 3/49 (6 %) | 1/50 (2 %) | 0.36 |
Nauseab | 2/49 (4 %) | 0/50 (0 %) | 0.24 |
Vomitingb | 1/48 (2 %) | 0/50 (0 %) | 0.49 |
Diarrheab | 3/48 (6 %) | 1/50 (2 %) | 0.36 |
Mode of delivery | |||
Spontaneous vertex delivery | 19/52 (37 %) | 10/51 (20 %) | 0.16 |
Vacuum/Forceps delivery | 4/52 (8 %) | 5/51 (9.8 %) | |
Cesarean delivery | 29/52 (56 %) | 36/51 (71 %) | |
n = 52 | n = 51 | ||
Estimated blood loss (ml) | 300 [213–475] | 300 [300–400] | 0.80 |
n = 48 | n = 50 | ||
VNRS SMBGc | 9 [8-10] | 9 [8-10] | 0.46 |
VNRS Allocated Medicined | 9 [1-10] | 9 [1-10] | 0.23 |
n = 52 | n = 51 | ||
Birth weight (kg) | 2.51 ± 0.61 | 2.66 ± 0.56 | 0.21 |
n = 52 | n = 51 | ||
Apgar Score at 1 minute | 9 [9] | 9 [9] | 0.68 |
Apgar Score at 5 minutes | 10 [10] | 10 [10] | 0.23 |
n = 46 | n = 50 | ||
Umbilical arterial blood pH | 7.30 [7.24–7.35] | 7.32 [7.25–7.35] | 0.43 |
n = 45 | n = 47 | ||
Umbilical arterial base deficit | 2.1 [0.7–4.4] | 1.8 [0.8–3.7] | 0.52 |
SCN/NICUe Admission | 18/52 (35 %) | 14/51 (28 %) | 0.43 |
Indication for NICU admission | |||
Prematurity | 6 (33.3 %) | 4 (28.6 %) | 0.59 |
Transient tachypnea of newborn | 5 (27.8 %) | 2 (14.3 %) | |
Presumed sepsis | 2 (11.1 %) | 4 (28.6 %) | |
Othersf | 5 (27.8 %) | 4 (28.6 %) |